Move to replace Pap smear with HPV test meets with skepticism | LOS ANGELES (Reuters) - U.S. health experts recommended that a test for cancer-causing strains of the human papillomavirus (HPV) be approved to replace Pap smears in screening most women for cervical cancer, but the plan met with some skepticism within the medical community. | | | | | | Partisanship engulfs U.S. Congress effort to avoid doctor pay cut | WASHINGTON (Reuters) - A bipartisan deal in Congress to spare doctors from recurring Medicare pay cuts was in jeopardy on Thursday, as Republicans ignored protests from physicians and moved forward with legislation that would use the so-called "doc fix" to undermine Obamacare. | | | | | | FDA chief defends new pain drug despite worries about abuse | WASHINGTON (Reuters) - The head of the Food and Drug Administration on Thursday defended the agency's approval of Zohydro, a powerful prescription opioid made by Zogenix Inc, saying it offers a "unique" option to treat pain despite concerns about potential abuse. | | | | UK to fast-track some drugs under early access scheme | LONDON (Reuters) - Britain is to accelerate access to ground-breaking drugs for serious conditions under a new early-access plan that the government hopes will benefit both patients and pharmaceutical companies. | | | Survival post-surgery linked to hospital differences | NEW YORK (Reuters Health) - Disparities between rich and poor in who survives major cancer surgeries may have more to do with the hospitals where they're treated than with individuals' wealth or lack of it, a new study suggests. | | | | | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment